Submitted by Anonymous (not verified) on 7 January 2025 - 10:46
Human medicines European public assessment report (EPAR): Aimovig, erenumab, Date of authorisation: 26/07/2018, Revision: 12, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Aimovig, erenumab, Date of authorisation: 26/07/2018, Revision: 12, Status: Authorised